Literature DB >> 15653756

Serine 68 of phospholemman is critical in modulation of contractility, [Ca2+]i transients, and Na+/Ca2+ exchange in adult rat cardiac myocytes.

Jianliang Song1, Xue-Qian Zhang, Belinda A Ahlers, Lois L Carl, JuFang Wang, Lawrence I Rothblum, Richard C Stahl, J Paul Mounsey, Amy L Tucker, J Randall Moorman, Joseph Y Cheung.   

Abstract

Overexpression of phospholemman (PLM) in normal adult rat cardiac myocytes altered contractile function and cytosolic Ca2+ concentration ([Ca2+]i) homeostasis and inhibited Na+/Ca2+ exchanger (NCX1). In addition, PLM coimmunoprecipitated and colocalized with NCX1 in cardiac myocyte lysates. In this study, we evaluated whether the cytoplasmic domain of PLM is crucial in mediating its effects on contractility, [Ca2+]i transients, and NCX1 activity. Canine PLM or its derived mutants were overexpressed in adult rat myocytes by adenovirus-mediated gene transfer. Confocal immunofluorescence images using canine-specific PLM antibodies demonstrated that the exogenous PLM or its mutants were correctly targeted to sarcolemma, t-tubules, and intercalated discs, with little to none detected in intracellular compartments. Overexpression of canine PLM or its mutants did not affect expression of NCX1, sarco(endo)plasmic reticulum Ca(2+)-ATPase, Na(+)-K(+)-ATPase, and calsequestrin in adult rat myocytes. A COOH-terminal deletion mutant in which all four potential phosphorylation sites (Ser62, Ser63, Ser68, and Thr69) were deleted, a partial COOH-terminal deletion mutant in which Ser68 and Thr69 were deleted, and a mutant in which all four potential phosphorylation sites were changed to alanine all lost wild-type PLM's ability to modulate cardiac myocyte contractility. These observations suggest the importance of Ser68 or Thr69 in mediating PLM's effect on cardiac contractility. Focusing on Ser68, the Ser68 to Glu mutant was fully effective, the Ser63 to Ala (leaving Ser68 intact) mutant was partially effective, and the Ser68 to Ala mutant was completely ineffective in modulating cardiac contractility, [Ca2+]i transients, and NCX1 currents. Both the Ser63 to Ala and Ser68 to Ala mutants, as well as PLM, were able to coimmunoprecipitate NCX1. It is known that Ser68 in PLM is phosphorylated by both protein kinases A and C. We conclude that regulation of cardiac contractility, [Ca2+]i transients, and NCX1 activity by PLM is critically dependent on Ser68. We suggest that PLM phosphorylation at Ser68 may be involved in cAMP- and/or protein kinase C-dependent regulation of cardiac contractility.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15653756     DOI: 10.1152/ajpheart.01133.2004

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  33 in total

1.  Amino acid substitutions in the FXYD motif enhance phospholemman-induced modulation of cardiac L-type calcium channels.

Authors:  Kai Guo; Xianming Wang; Guofeng Gao; Congxin Huang; Keith S Elmslie; Blaise Z Peterson
Journal:  Am J Physiol Cell Physiol       Date:  2010-08-18       Impact factor: 4.249

2.  Altered contractility and [Ca2+]i homeostasis in phospholemman-deficient murine myocytes: role of Na+/Ca2+ exchange.

Authors:  Amy L Tucker; Jianliang Song; Xue-Qian Zhang; Jufang Wang; Belinda A Ahlers; Lois L Carl; J Paul Mounsey; J Randall Moorman; Lawrence I Rothblum; Joseph Y Cheung
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-06-02       Impact factor: 4.733

3.  Intracellular trafficking of FXYD1 (phospholemman) and FXYD7 proteins in Xenopus oocytes and mammalian cells.

Authors:  Shiri Moshitzky; Carol Asher; Haim Garty
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

4.  Phospholemman inhibition of the cardiac Na+/Ca2+ exchanger. Role of phosphorylation.

Authors:  Xue-Qian Zhang; Belinda A Ahlers; Amy L Tucker; Jianliang Song; JuFang Wang; J Randall Moorman; J Paul Mounsey; Lois L Carl; Lawrence I Rothblum; Joseph Y Cheung
Journal:  J Biol Chem       Date:  2006-01-23       Impact factor: 5.157

5.  FXYD1 phosphorylation in vitro and in adult rat cardiac myocytes: threonine 69 is a novel substrate for protein kinase C.

Authors:  William Fuller; Jacqueline Howie; Linda M McLatchie; Roberta J Weber; C James Hastie; Kerry Burness; Davor Pavlovic; Michael J Shattock
Journal:  Am J Physiol Cell Physiol       Date:  2009-04-01       Impact factor: 4.249

6.  Cardiac-restricted overexpression of the A(2A)-adenosine receptor in FVB mice transiently increases contractile performance and rescues the heart failure phenotype in mice overexpressing the A(1)-adenosine receptor.

Authors:  Tung O Chan; Hajime Funakoshi; Jianliang Song; Xue-Qian Zhang; JuFang Wang; Paul H Chung; Brent R DeGeorge; Xue Li; Jin Zhang; David E Herrmann; Maura Diamond; Eman Hamad; Steven R Houser; Walter J Koch; Joseph Y Cheung; Arthur M Feldman
Journal:  Clin Transl Sci       Date:  2008-09       Impact factor: 4.689

Review 7.  Calcium signaling in cardiac myocytes.

Authors:  Claire J Fearnley; H Llewelyn Roderick; Martin D Bootman
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-11-01       Impact factor: 10.005

8.  Overexpression of the Na+/K+ ATPase α2 but not α1 isoform attenuates pathological cardiac hypertrophy and remodeling.

Authors:  Robert N Correll; Petra Eder; Adam R Burr; Sanda Despa; Jennifer Davis; Donald M Bers; Jeffery D Molkentin
Journal:  Circ Res       Date:  2013-11-11       Impact factor: 17.367

9.  Regulation of L-type calcium channel by phospholemman in cardiac myocytes.

Authors:  Xue-Qian Zhang; JuFang Wang; Jianliang Song; Joseph Rabinowitz; Xiongwen Chen; Steven R Houser; Blaise Z Peterson; Amy L Tucker; Arthur M Feldman; Joseph Y Cheung
Journal:  J Mol Cell Cardiol       Date:  2015-04-25       Impact factor: 5.000

10.  Phospholemman and beta-adrenergic stimulation in the heart.

Authors:  JuFang Wang; Erhe Gao; Jianliang Song; Xue-Qian Zhang; Jifen Li; Walter J Koch; Amy L Tucker; Kenneth D Philipson; Tung O Chan; Arthur M Feldman; Joseph Y Cheung
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-11       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.